Laser vs. bipolar prostate vaporization in bleeding-prone patients: a randomized trial and cutting-edge analysis
World Journal of Urology · 2025
DOI: 10.1007/s00345-025-05692-4 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift World Journal of Urology, 2025. Verfasst von Ahmed A Shorbagy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Transurethral Resection of Prostate, Laser Therapy, Lasers, Semiconductor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ain Shams University.
Abstract (Originalsprache)
Purpose
To compare effectiveness and safety of transurethral diode laser vaporization of prostate (diode LVP) versus bipolar transurethral vaporization of prostate (B-TUVP) in symptomatic benign prostatic hyperplasia (BPH) patients receiving oral anticoagulants/anti-platelet drugs. Patients and methods All symptomatic prostate patients receiving oral anticoagulants/anti-platelet drugs are prospectively enrolled in the study between January 2023 to May 2024 in our institution. Of total 98 patients were randomized to B-TUVP (48 patients) or diode LVP (50 patients). The primary outcome is to compare B-TUVP with diode LVP regarding operative bleeding and postoperative hemoglobin drop. Secondary outcomes assess time of urinary irrigation, time of urethral catheter removal, length of hospital stays, and 6-month postoperative functional outcomes; IPSS, postoperative flow rate, and postvoid residual urine.
Results
Baseline characteristics were similar in both groups. Diode LVP group had a significantly higher postoperative hemoglobin with a lower drop compared to B-TUVP group (p = 0.032, p = 0.007; respectively). The diode LVP group had a significantly reduced urinary irrigation duration compared to the B-TUVP group (p = 0.031). Also, diode LVP patients had early catheter removal compared to those in the B-TUVP group (p = 0.014). Additionally, the diode group had a notably reduced hospital stay duration compared to the B-TUVP group (p = 0.024). There were no significant differences between both groups regarding 6-month postoperative IPSS, Q max and PVRU.
Conclusion
Diode LVP of the prostate is a safer alternative for treating BPH with fewer risks compared to B-TUVP especially in patients receiving anticoagulants. Nonetheless, both treatments yield similar 6-months functional outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Ain Shams University, Cairo, Egypt.
- Department of Urology, Aswan University, Aswan, Egypt. dr.peter444@gmail.com.
Förderung
- Ain Shams University
Zitieren
APA
Shorbagy, A. A., Ismail, M., Kotb, Y. M., Desouki, M., Shabayek, M., & Hanna, P. (2025). Laser vs. bipolar prostate vaporization in bleeding-prone patients: a randomized trial and cutting-edge analysis. World Journal of Urology. https://doi.org/10.1007/s00345-025-05692-4
Vancouver
Shorbagy AA, Ismail M, Kotb YM, Desouki M, Shabayek M, Hanna P. Laser vs. bipolar prostate vaporization in bleeding-prone patients: a randomized trial and cutting-edge analysis. World Journal of Urology. 2025. doi:10.1007/s00345-025-05692-4
BibTeX
@article{Shorbagy2025,
author = {Shorbagy, Ahmed A and Ismail, Mohammed and Kotb, Youssef M and Desouki, Mohamed and Shabayek, Mohamed and Hanna, Peter},
title = {Laser vs. bipolar prostate vaporization in bleeding-prone patients: a randomized trial and cutting-edge analysis},
journal = {World Journal of Urology},
year = {2025},
doi = {10.1007/s00345-025-05692-4}
}
EUVIMED